Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
243.60    -10.60 (-4.17%)
Bid:
243.60
Ask:
243.80
Spread: 0.20 (0.082%)
Market Cap: £2.13b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Update on share buyback programmes

13 Oct 2023 07:00

RNS Number : 9954P
Bridgepoint Group plc
13 October 2023

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

Bridgepoint Group plc ("Bridgepoint")

Completion of share buyback programme and commencement of New Buyback Programme

Further to Bridgepoint's announcement on 2 October 2023, Bridgepoint announces that yesterday it commenced the share buyback programme of up to £50 million detailed in the announcement of 2 October 2023 (the "New Buyback Programme"), following completion on 11 October 2023 of the share buyback programme of up to £50 million announced on 24 January 2023. The New Buyback Programme is envisaged to complete before 31 July 2024.

ENQUIRIES

Bridgepoint

Analysts and investors

Adam Key

adam.key@bridgepoint.eu

+44 7833 748010

Media

Christian Jones / James Murray

christian.jones@bridgepoint.eu james.murray@bridgepoint.eu

+44 20 7034 3500

FGS Global (Public Relations Adviser to Bridgepoint)

Charles O'Brien / +44 20 7251 3801 / +44 7825 043 656

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint@fgsglobal.com

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSUUUWROOURAAA
Date   Source Headline
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20237:00 amRNSTransaction in Own Shares
21st Feb 20237:00 amRNSTransaction in Own Shares
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20237:00 amRNSTransaction in Own Shares
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20233:00 pmRNSFormation of ESG Committee
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20237:00 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20237:00 amRNSShare Buyback Programme
22nd Dec 20227:00 amRNSHolding(s) in Company
28th Nov 20226:01 pmRNSStatement regarding Press Speculation
23rd Nov 20227:00 amRNSDirectorate Change
16th Nov 20227:00 amRNSTrading Statement
23rd Sep 202210:10 amRNSDirector/PDMR Shareholding
12th Sep 20223:11 pmRNSChange of Registered Office
5th Aug 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSHalf-year Report
13th May 20227:00 amRNSResult of AGM
6th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20223:00 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSAnnual Report and Accounts and Notice of AGM
24th Mar 20227:00 amRNSPreliminary Results
22nd Mar 20223:00 pmRNSDirector Declaration
16th Dec 20218:56 amRNSDirector Declaration
16th Nov 20217:00 amRNSQuarterly Trading Update
21st Sep 20219:57 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSHalf-Year Update 2021
28th Jul 20214:42 pmRNSHolding(s) in Company
26th Jul 202110:15 amRNSHolding(s) in Company
26th Jul 20218:10 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.